MiNK Therapeutics(INKT) - 2023 Q3 - Earnings Call Transcript

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2023 Earnings Call November 9, 2023 8:30 AM ET Company Participants Zack Armen – Head, Investor Relations Jennifer Buell - President and Chief Executive Officer Marc Van Dijk - Chief Scientific Officer Christine Klaskin – Principal Financial and Accounting Officer Conference Call Participants Emily Bodnar – H.C. Wainwright Jack Allen – Baird Brandon Carney - B. Riley Matthew Phipps – William Blair Operator Good morning, and welcome to MiNK Therapeutics' Third Quarter ...